LAST CHANCE TO SAVE! New Trends for Life Sciences at PACK EXPO Southeast
Discover all the latest packaging solutions for life sciences products at the all-new PACK EXPO Southeast in Atlanta, GA, March 10-12, 2025
REGISTER ASAP FOR $30!

Phillips-Medisize to be Acquired by Molex LLC

Phillips-Medisize is a portfolio company of San Francisco, CA-based Golden Gate Capital, a private equity investment firm with approximately $15 billion of capital under management.

This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.

Phillips-Medisize Corporation (Phillips-Medisize), a global leader in outsource design, development and manufacturing services for the medical industry announced today that it has entered into a binding agreement to be acquired by Molex LLC (Molex), a global manufacturer of complete interconnect solutions.

Molex designs and manufactures electronic, electrical and fiber optic systems and solutions. As one of the world’s largest interconnect companies, Molex employs over 40,000 people in more than 40 countries.

“Molex and Phillips-Medisize share a similar culture and approach to managing the business that creates strong partnerships built on quality and innovation,” said Matt Jennings, chairman, president and CEO, Phillips-Medisize Corporation. “Molex’s global scale in electronics, coupled with Phillips-Medisize’s strength in designing and manufacturing innovative products for medical device customers, will help us become a global leader in connected health solutions.”

“Phillips-Medisize has a talented, experienced and innovative team that has strong customer relationships because of its outstanding ability to serve the unique needs of the medical solutions market,” said Tim Ruff, senior vice president of business development and corporate strategy, Molex LLC. “Combined with Molex’s expertise in electronics and broad global manufacturing presence, we are confident that together we can significantly expand our medical solutions capabilities globally.”

Rajeev Amara, a Managing Director of Golden Gate Capital stated, "In just three years of our ownership, Phillips-Medisize has executed on a transformative vision to become a global leader in the manufacturing of biologics drug delivery devices. We would like to thank all the employees for their hard work and wish them well in the future."

Terms of the transaction were not disclosed. The transaction is subject to customary closing conditions and is expected to close in the fall.

LAST CHANCE TO SAVE! New Tech for Life Sciences at PACK EXPO Southeast
The exciting new PACK EXPO Southeast 2025 unites all vertical markets in one dynamic hub, generating more innovative answers to packaging challenges for life sciences products. Don’t miss this extraordinary opportunity for your business!
REGISTER ASAP FOR $30!
LAST CHANCE TO SAVE! New Tech for Life Sciences at PACK EXPO Southeast